Finding:

1. close

   Advaxis

   Advaxis uses live genetically modified Listeria monocytogenes to treat cancers, infectious disease and problems of the immune system. ... "Advaxis Enrolls Patients to Cervical Cancer Vaccine Trial", Genetic Engineering News.
2. close

   Cancer vaccine

   The term cancer vaccine refers to a vaccine that either prevents infections with cancer-causing viruses, or treats existing cancer. ... Several cancer vaccines are currently in development by companies such as Antigenics Inc. (Oncophage), Pharmexxa A/S (GV1001), Onyvax Limited (Onyvax-P), Geron Corporation (GRNVAC1), Dendreon Corp (Provenge), Cell Genesys Inc (GVAX),Advaxis, Inc (Lovaxin C), Accentia Biopharmaceuticals majority owned subsidiary Biovest International [BiovaxID], GeneMax Corp (GMXX) and Apthera, Inc. (NeuVax).
3. close

   Lovaxin C

   It is under development at Advaxis. ... In phase I/II trials 15 women with end-stage (IVb) cervical cancer were treated.

Explore the following pages on Powerset:

• Advaxis,
• Cancer vaccine,
• Lovaxin C